CompletedNot Applicable

Timing of Coronary Angiography, Cardiac Surgery, and Adverse Renal and Cardiac Events (MARCE)

United States965 participantsStarted 2015-01

Plain-language summary

1. To examine two main predictor variables independently and then jointly in stratified and multivariate analyses for the outcomes of CSA-AKI, MARCE, need for RRT, and inpatient mortality, and the composite, as well as the outcomes of 30 day rehospitalization or death, and finally for the days out of hospital and alive adjusted to person-year of time 1. Days from coronary angiogram performed with IOCM to cardiac surgery (1, 2, 3, etc) 2. Thakar Acute Renal Failure (ARF) score (1 to 17) 2. To examine the interrelationships between time in days between angiogram and surgery and the ARF Score with the Society of Thoracic Surgery (STS) Risk score for mortality

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Cardiac surgery with or without cardiac valve surgery
✓. At least one baseline and postoperative serum creatinine (mg/dl)

Exclusion criteria

✕. Use of contrast agent other than IOCM with the preoperative angiogram
✕. Preoperative use of ventricular assist devices and intraaortic balloon counterpulsation.
✕. Operations where there is implantation of mechanical assist devices or cardiac transplant

What they're measuring

Contrast-induced acute kidney injury

Timeframe: 7 days

Cardiac surgery associated acute kidney injury

Timeframe: 7 days

Major adverse renal and cardiac events

Timeframe: 30 days

Trial details

NCT IDNCT02332070

SponsorBaylor Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-02

View on ClinicalTrials.gov More Acute Kidney Injury trials